Pangali P/E NKGen Biotech Inc (NKGN)
The price action of NKGen Biotech, Inc. (NKGN) securities allows for an assessment of the effectiveness of developing NK-cell-based therapies to combat dementia, where the indicator stands at -0.10. NKGen Biotech, Inc. (NKGN) focuses on creating cellular products in the US and South Korea while protecting its digital intellectual property. Operational activities rely on strict FDA regulations for biomaterial processing, ensuring a baseline level of environmental safety.
Rincian analitis perusahaan NKGen (NKGN)
- rega saiki lan proyeksi nilai saham:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- informasi babagan utang lan solvabilitas:
Rasio Utang marang Ekuitas NKGen Biotech, Inc.|NKGN - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal NKGen Biotech Corp|NKGN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NKGen Biotech, Inc.|NKGN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak NKGen Biotech|Likuiditas darurat nkgenbiotech.com
- data bathi lan kelipatan valuasi:
NKGN - Penghasilan resik|Bathi resik mangsa ngarep NKGen Biotech, Inc.|NKGN - Pangali P/E|Rasio prakiraan rega marang bathi NKGen Biotech Inc|NKGN - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NKGen Biotech, Inc.|NKGN - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku NKGen Biotech|NKGN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan nkgenbiotech.com|NKGN - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NKGen Biotech, Inc.
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:nkgenbiotech.com
NKGen Biotech, Inc. (NKGN) develops cell therapies for neurodegenerative pathologies in the US and South Korea. The efficacy of clinical trials directly impacts net income, forming the basis for calculating the P/E ratio. This multiple determines the cost per unit of earnings, reflecting investor market expectations. High values indicate a premium for future growth. By analyzing the P/E ratio chart for NKGen Biotech, Inc. (NKGN), one can assess the risk of overpayment amid tight monetary policy.
Pesaing wigati
Pangali rega marang bathi BIIB (biogen.com)|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Pangali P/E Regencell Bioscience Ltd (RGC)|Pangali P/E AXSM (Axsome Therapeutics Inc)|Rasio kapitalisasi marang bathi resik ACADIA Corp|Xenon Pharmaceuticals - Pangali P/E|Kapitalisasi marang bathi vikingtherapeutics.com|Supernus (SUPN) - Rasio rega marang bathi|Pangali rega marang bathi CPRX|Koefisien rega marang bathi DNLI|HRMY: Nilai perusahaan marang bathi resik|Pangali P/E BHVN|Rasio rega marang bathi AMLX (amylyx.com)|Pangali P/E TRVI (Trevi Therapeutics, Inc.)|Periode bali modal bisnis Praxis Precision Medicines Inc (PRAX)|AVXL - Rasio rega marang bathi|Kapitalisasi marang bathi CeriBell EEG|PRTA (prothena.com) - Koefisien rega marang bathi|ALEC: Rasio rega pasar marang bathi resik|ANNX (Annexon) - Pangali P/E|Kapitalisasi marang bathi Omeros Corp. OMER|Pangali P/E NGNE|Koefisien rega marang bathi AC Immune Inc ACIU|Pangali P/E VYGR (Voyager Therapeutics)|Nilai perusahaan marang bathi resik NMRA|SCLX: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik TVGN (Tevogen Bio Holdings Inc.)|ACOG: Pangali P/E|CGTX - Periode bali modal bisnis|Rasio rega marang bathi Inhibikase Therapeutics|Pangali rega marang bathi SAVA (cassavasciences.com)|Pangali P/E ASRT|Koefisien rega marang bathi coyatherapeutics.com COYA|Vistagen - Koefisien rega marang bathi|Periode bali modal bisnis Ovid Therapeutics Inc (OVID)|ABOS - Rasio rega marang bathi|CRVO (cervomed.com) - Pangali rega marang bathi|alteritytherapeutics.com (ATHE) - Rasio rega marang bathi|Clene (CLNN) - Pangali P/E|PEPG (PepGen Inc) - Pangali P/E|JUNS - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi Relmada Therapeutics (RLMD)|annovisbio.com - Pangali rega marang bathi|Rasio rega marang bathi Grace Therapeutics GRCE|AIFF: Pangali rega marang bathi|ANEW Medical, Inc. - Pangali P/E|Kapitalisasi marang bathi NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals) - Koefisien rega marang bathi|MetaVia (MTVA) - Pangali P/E|Rasio rega marang bathi NeurAxis|HSDT: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Passage Bio, Inc. (PASG)|NEUP - Kapitalisasi marang bathi|Rasio rega marang bathi Minerva Neurosciences NERV|ATHA: Pangali rega marang bathi|ADXN - Rasio rega marang bathi|ALZN - Pangali P/E|CYCN: Pangali P/E|Rasio kapitalisasi marang bathi resik Protagenic Therapeutics, Inc. PTIX|KTTA (Pasithea Therapeutics Corp) - Pangali P/E|Kapitalisasi marang bathi Cortigent Medical CRGT|Rasio rega marang bathi Avenue Therapeutics, Inc. (ATXI)|Brainstorm Cell Therapeutics Inc. - Pangali rega marang bathi|Cara Therapeutics, Inc - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik CHRO|Eliem - Pangali P/E|ITCI: Rasio rega marang bathi|LBPH: Pangali P/E|MRNS - Periode bali modal bisnis|Rasio rega marang bathi NeuroBo|Kapitalisasi marang bathi Sage Therapeutics Inc SAGE|Koefisien rega marang bathi SNPX (Synaptogenix, Inc.)|Rasio rega pasar marang bathi resik TRVN|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|anewmeds.com (WENA) - Kapitalisasi marang bathi|Cerevel - Pangali P/E
